Institutional Ownership Acrivon Therapeutics, Inc. (ACRV)
This table provides information about the institutional ownership of Acrivon Therapeutics, Inc. (ACRV). We have compiled data on the 53 institutions that hold shares in the stock, with a total of 23.2 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ra Capital Management, L.P.
Boston, MA |
Nov 14, 2024 Q3 2024 |
8,340,508
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
5,360,858
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 78.23%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
2,140,628
shares
|
$0
0.0% of portfolio
|
Q3 2024
Added 0.99%
|
|
|
Sands Capital Ventures, LLC
Arlington, VA |
Nov 13, 2024 Q3 2024 |
2,122,605
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 28.44%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
888,130
shares
|
$0
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
809,859
shares
|
$0
0.0% of portfolio
|
Q3 2024
Reduced 14.65%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
767,020
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 3.11%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
637,538
shares
|
$0
0.0% of portfolio
|
Q3 2024
Reduced 14.48%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
302,103
shares
|
$0
0.0% of portfolio
|
Q3 2024
Reduced 2.04%
|
|
|
Health Cor Management, L.P.
New York, NY |
Feb 14, 2023 Q4 2022 |
284,201
shares
|
$0
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
225,896
shares
|
$0
0.0% of portfolio
|
Q3 2024
Added 26.44%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
198,168
shares
|
$0
0.0% of portfolio
|
Q3 2024
Added 712.7%
|
|
|
Exome Asset Management LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
116,757
shares
|
$0
0.56% of portfolio
|
Q3 2024
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
116,253
shares
|
$0
0.0% of portfolio
|
Q3 2024
Reduced 19.25%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Nov 14, 2024 Q3 2024 |
112,414
shares
|
$0
0.0% of portfolio
|
Q3 2024
Reduced 7.36%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
105,398
shares
|
$0
0.0% of portfolio
|
Q3 2024
Reduced 7.59%
|
|
|
Ubs Oconnor LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
79,249
shares
|
$0
0.0% of portfolio
|
Q3 2024
Reduced 24.7%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2024 Q3 2024 |
76,981
shares
|
$0
0.0% of portfolio
|
Q3 2024
Added 32.31%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
52,885
shares
|
$0
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
45,900
shares
|
$0
0.0% of portfolio
|
Q3 2024
Reduced 15.78%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
39,750
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Prelude Capital Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
37,727
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
35,914
shares
|
$0
0.0% of portfolio
|
Q3 2024
Added 108.21%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
33,991
shares
|
$0
0.0% of portfolio
|
Q3 2024
Added 548.31%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
33,306
shares
|
$0
0.0% of portfolio
|
Q3 2024
Added 51.16%
|